dobutamine + dextrose

This product is a **fixed-dose intravenous solution** combining dobutamine, a synthetic catecholamine and direct-acting inotrope (primarily a beta-1 adrenergic agonist), with dextrose, an intravenous sugar solution used as a diluent and to prevent hypoglycemia during infusion. It is used for **short-term inotropic support** for patients with cardiac decompensation due to depressed contractility from organic heart disease or following cardiac surgery. Dobutamine increases myocardial contractility and cardiac output, primarily by stimulating beta-1 adrenergic receptors on the heart, with secondary mild effects on beta-2 (vasodilation) and alpha-1 (vasoconstriction) receptors. Dextrose serves as the vehicle for parenteral administration and helps maintain blood glucose during treatment. The solution is administered **intravenously** and is not intended for long-term heart failure management due to increased risk observed with chronic inotrope therapy[2][3][5][6].

Other names

dobutamine in 5% dextrosedobutamine and dextrose injectiondobutamine hydrochloride in 5% dextrosedobutamine in dextrose